Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Optixon 1-Day

K-Number: K201013 · 2020-09-18

ApplicantOptixon, Inc.
Decision Date2020-09-18
Product CodeLPL
Advisory CommitteeOP
DecisionSubstantially Equivalent

Device Summary

Optixon 1-Day is the device name listed in this FDA 510(k) record. The listed applicant is Optixon, Inc.. It received FDA 510(k) clearance on 2020-09-18 under 510(k) number K201013. The device is classified under product code LPL. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Optixon 1-Day?

Optixon 1-Day is a medical device that received FDA 510(k) clearance on 2020-09-18. The listed applicant is Optixon, Inc.. The 510(k) number is K201013.

When did Optixon 1-Day receive FDA 510(k) clearance?

Optixon 1-Day received FDA 510(k) clearance on 2020-09-18, under 510(k) number K201013.

Who is the listed applicant for Optixon 1-Day?

The FDA 510(k) record lists Optixon, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Optixon 1-Day?

The FDA product code for Optixon 1-Day is LPL.

Related Devices (Code: LPL)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.